ProShares UltraPro Short QQQ ETF vs GeneDx Holdings Corp — how do they compare? ProShares UltraPro Short QQQ ETF trades at $40.47, while GeneDx Holdings Corp trades at $61.92 (market cap $1.80B). The key difference: GeneDx Holdings Corp is trading nearer its 52-week high, ProShares UltraPro Short QQQ ETF nearer its low. Which is the better fit depends on your goals.
| SQQQ | WGS | |
|---|---|---|
Sector | Leveraged / Inverse | Technology |
52-Week High | $97.60 | $167.51 |
52-Week Low | $36.31 | $34.51 |
Market Cap | — | $1.80B |
Enterprise Value | — | $1.80B |
Trailing returns across standard periods
SQQQ is a leveraged inverse ETF that seeks daily investment results, before fees and expenses, that correspond to three times the inverse (-3x) of the daily performance of the Nasdaq-100 Index. It is a tactical trading tool designed for sophisticated investors to profit from or hedge against declines in large-cap technology and growth stocks. Due to its daily reset and the effects of compounding, it is intended for short-term use and carries significant risk if held during periods of high market volatility.
Read more on SQQQ →GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →